Application of wall-broken ganoderma lucidum powder in treatment of prostatitis
Through the preparation of broken wall powder of Ganoderma lucidum, the problem of poor safety of existing prostatitis agents is solved, and the efficient dissolution and significant efficacy of Ganoderma lucidum active ingredients are achieved, providing a safe and efficient treatment plan.
Patent Information
- Application Number
- CN202411194740.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-11-08
AI Technical Summary
The current prostatitis agents are poor in safety and it is difficult to effectively use the active ingredients of Ganoderma lucidum for treatment.
The preparation method of Ganoderma lucidum wall-breaking powder, including sterilization and ultrafine pulverization, is used to prepare Ganoderma lucidum ultrafine powder with a particle size of 2-30μm, which improves the dissolution amount and efficacy of the active ingredients, and forms suitable through combination with pharmaceutical excipients. Pharmaceutical preparations.
It significantly improves the efficacy of Ganoderma lucidum on prostatitis, has high safety and few side effects, provides a new treatment option, and expands the application of Ganoderma lucidum in the medical field.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of application and preparation of traditional Chinese medicine, and relates to a new application of ganoderma lucidum. Background Art
[0002] The disclosure of this background information is intended to enhance understanding of the general background of the invention and should not necessarily be taken as an acknowledgment or any form of suggestion that this information constitutes the prior art already known to a person skilled in the art.
[0003] Benign prostatitis is one of the common urogenital diseases in men. Its clinical manifestations include bladder irritation and obstruction symptoms, which can have a serious impact on the patient's physical health and quality of life. Prostatitis not only reduces the patient's quality of life, but also creates a considerable burden on the family. Conventional treatment mainly uses Western medicine, which has a quick effect but has significant side effects.
[0004] Ganoderma lucidum Ganoderma lucidum Ganoderma lucidum Ganoderma sinense The dried fruiting body of Ganoderma lucidum. It has the functions of replenishing qi and calming the mind, relieving cough and relieving asthma. Due to the special hardness of Ganoderma lucidum, it is difficult to extract its active ingredients by conventional Chinese medicine decoction methods. The method of taking powder with water can better retain the active ingredients. At present, there is no report on the therapeutic effect of Ganoderma lucidum on benign prostatitis. Summary of the invention
[0005] In view of the problem of poor safety of current prostatitis drugs, the present invention provides a use of Ganoderma lucidum in treating prostatitis, which has reliable efficacy and high safety.
[0006] To achieve the above purpose, the present invention adopts the following technical solution.
[0007] An application of Ganoderma lucidum in treating prostatitis.
[0008] The ganoderma lucidum is a raw product or a processed product; preferably, the ganoderma lucidum is a broken wall powder.
[0009] The preparation method of the above-mentioned ganoderma lucidum wall-broken powder comprises the following steps: (1) Sterilize the Ganoderma lucidum fruiting body and crush it into fine powder; (2) Ultrafine grinding the fine powder to a particle size of 2-30 μm to obtain Ganoderma lucidum wall-broken powder.
[0010] The sterilization is irradiation sterilization, microwave sterilization or high temperature and high pressure sterilization, preferably microwave sterilization; the microwave sterilization time is 1.5-5min; the microwave power is 400-600W.
[0011] The fineness of the fine powder is 10-120 meshes.
[0012] In order to facilitate sterilization and crushing, the Ganoderma lucidum fruiting body is sliced, and the thickness of the slice is 2-5 mm.
[0013] The ultrafine grinding is dry grinding, and the methods of air flow grinding, vibration ultrafine grinding, ball milling ultrafine grinding, hammering ultrafine grinding and self-grinding ultrafine grinding can be selected.
[0014] A ganoderma lucidum wall-broken powder prepared by the above method, whose moisture content is not higher than 17%, water-soluble extract is not less than 3.0%, polysaccharide content is not less than 0.90%, triterpenoid and sterol content is not less than 0.50%; particles larger than 30µm in the powder do not exceed 10%, and there are no particles larger than 40µm.
[0015] The determination method for moisture and water-soluble extract (hot soaking method) shall be in accordance with the "Moisture" and "Extract" in the 2020 edition of the "Pharmacopoeia of the People's Republic of China"; the determination method for polysaccharide content, triterpenoid and sterol content shall be in accordance with the determination method under Ganoderma lucidum in Part I of the 2020 edition of the "Pharmacopoeia of the People's Republic of China"; the particle size inspection method shall be in accordance with the "Particle Size and Particle Size Distribution Determination Method" in the 2020 edition of the "Pharmacopoeia of the People's Republic of China".
[0016] The ganoderma lucidum wall-broken powder can be used alone or mixed with other ingredients to treat prostatitis and prepared into a medicine for treating prostatitis.
[0017] Pharmaceutically acceptable excipients may also be included to adjust the use mode of the drug, the shelf life or release rate of the active ingredient, etc. The drug can be processed into a preparation form, such as solid dosage forms such as granules, tablets, capsules, or liquid dosage forms such as syrups, wines, tinctures, etc.
[0018] The present invention has the following advantages: The ganoderma lucidum provided by the present invention has the effect of treating prostatitis. The ganoderma lucidum cells in the provided ganoderma lucidum wall-broken powder are broken, and the effective component dissolution amount is large, which obviously improves the therapeutic effect of ganoderma lucidum in treating prostatitis, and the effect is obviously better than that of ganoderma lucidum treated by ordinary methods; ganoderma lucidum is safe for treating prostatitis and has few side effects, which expands the medical use of ganoderma lucidum and provides a new drug option for the treatment of prostatitis. DETAILED DESCRIPTION
[0019] The present invention will be further described below in conjunction with examples, but the present invention is not limited by the following examples.
[0020] Example 1 Preparation of Ganoderma lucidum wall-broken powder 1. Sterilization conditions (1) Wash the collected dried fruiting bodies of the Polyporaceae fungus Ganoderma lucidum with water and cut them into slices with a thickness of 2-5 mm using a slicer; (2) Place the thick slices of Ganoderma lucidum fruiting body in a microwave oven and heat at high temperature (600W) for 1.5-5.0 minutes to sterilize; (3) Grinding the sterilized Ganoderma lucidum fruiting body slices into powder (10-120 meshes) in a grinder to obtain Ganoderma lucidum powder; (4) placing the Ganoderma lucidum powder in a jet mill and grinding it into 2-30 µm ultrafine powder to obtain Ganoderma lucidum ultrafine powder; (5) The quality control indicators of Ganoderma lucidum ultrafine powder include moisture content, water-soluble extract (hot soaking method), polysaccharide content, triterpenoid and sterol content and powder particle size: the determination method of moisture content and water-soluble extract (hot soaking method) shall be in accordance with the "moisture" and "extract" in the 2020 edition of the "Pharmacopoeia of the People's Republic of China"; the determination method of polysaccharide content, triterpenoid and sterol content shall be in accordance with the determination method under Ganoderma lucidum in Part I of the 2020 edition of the "Pharmacopoeia of the People's Republic of China"; the particle size inspection method shall be in accordance with the "Particle size and particle size distribution determination method" in the 2020 edition of the "Pharmacopoeia of the People's Republic of China".
[0021] Table 1 Effects of different microwave sterilization times on microorganisms and active ingredients of Ganoderma lucidum The requirement for oral Chinese medicine slices is that the total number of aerobic bacteria should not exceed 10 5 / g, total number of mold and yeast 10 3 / g, and Escherichia coli / g shall not be detected. As shown in Table 1, microwave sterilization can kill microorganisms well, and sterilization for 1.5-5.0min can meet the microbial requirements of oral direct consumption of decoction pieces, and the damage to active ingredients is relatively small.
[0022] 2. Particle size In order to observe the release rate of the active ingredients of Ganoderma lucidum powder with different crushed particle sizes in the medium, the release amount of Ganoderma lucidum polysaccharides, triterpenes and sterols was tested. The specific method is as follows: Take the sterilized thick slices of Ganoderma lucidum from the same batch and divide them into three equal parts. One part is left untreated, one part is crushed into 150-250µm powder, and one part is crushed into 2-30µm ultrafine powder. According to the second method (paddle method) of dissolution and release determination in Part IV 0931 of the 2020 edition of the "Pharmacopoeia of the People's Republic of China", the release rate of polysaccharides, triterpenes and sterols after 30 minutes of release (relative to the content in Ganoderma lucidum) is determined.
[0023] Table 2 Release rate of active ingredients of Ganoderma lucidum with different crushed particle sizes As shown in Table 2, the superfine powder releases almost all of its ingredients within 30 minutes, which is far superior to the thick slices and ordinary powder of Ganoderma lucidum. This is mainly because after Ganoderma lucidum is crushed into superfine powder, the cell structure is completely destroyed, and the active ingredients in the cells do not need to pass through the cell barrier when dissolving, so they are almost all released within 30 minutes. It can be seen that Ganoderma lucidum superfine powder can be used very well after taking it.
[0024] Example 2 Effect of Ganoderma Lucidum on Prostatitis (1) Wash the collected dried fruiting bodies of the Polyporaceae fungus Ganoderma lucidum with water and cut them into slices with a thickness of 2-5 mm using a slicer; (2) Place the thick slices of Ganoderma lucidum fruiting body in a microwave oven and heat at medium heat (400W) for 3.0 min to sterilize; (3) Grinding the sterilized Ganoderma lucidum fruiting body slices into 150-200 µm powder in a grinder to obtain Ganoderma lucidum ordinary fine powder; (4) The Ganoderma lucidum powder is placed in a jet mill and crushed into 2-30 µm ultrafine powder to obtain Ganoderma lucidum ultrafine powder.
[0025] Evaluation of the efficacy of the Ganoderma lucidum powder in steps (3) and (4) above on rats with chronic prostatitis model: 90 SD male rats, 10-12 weeks old, weighing 180-220g, were selected and raised in a laboratory environment with room temperature (20±3℃) and relative humidity of 40%-60%. The lighting lasted for 12 hours a day, and the rats were free to drink water and eat. After 5 days of adaptive feeding, the chronic prostatitis model was prepared by using estrogen-induced castrated rats: the rats were randomly divided into a sham operation group and a model operation group. All rats were anesthetized by intraperitoneal injection of 10% chloral hydrate (3.5mg / kg). The rats in the model operation group underwent bilateral orchiectomy, and the rats in the sham operation group had their vulva skin incised and freed, but the testicles were not removed, and the skin was then sutured. After surgery, penicillin (dose 250,000 U / kg) was injected intramuscularly at 0.1mL / rat every day for 3 consecutive days to prevent infection. The rats in the chronic prostatitis model group were subcutaneously injected with estradiol (dissolved in soybean oil for injection) at a dose of 0.25 mg / kg per day, once a day, for 30 consecutive days to obtain chronic prostatitis model rats. Rats in the sham operation group were only subcutaneously injected with the same volume of soybean oil once a day for 30 consecutive days.
[0026] The rats in the model surgery group were randomly divided into model group, Qianlie Kangshu capsule group, Ganoderma lucidum superfine powder group, Ganoderma lucidum ordinary fine powder group, 10 rats in each group, and the remaining 10 rats in the sham operation group, a total of 5 groups. The rats in the sham operation group and the model group were given 0.9% sodium chloride injection 5mL / d by gavage, the rats in the Qianlie Kangshu capsule group were given 1.8g / (kg·d) of Qianlie Kangshu capsule liquid (with 0.9% sodium chloride injection 5mL as solvent) by gavage, and the Ganoderma lucidum superfine powder group and Ganoderma lucidum ordinary fine powder group were given 1.5g / (kg·d) (dispersed with 0.9% sodium chloride injection 5mL solvent) by gavage every day, once a day, for 30 consecutive days.
[0027] The rats were weighed 2 h after administration on the first day (after model establishment), the tenth day, and the thirtieth day.
[0028] Table 3 Comparison of body weight of rats in each group Note: Compared with the sham operation group, P<0.05; compared with the model group, △ P<0.05; compared with the Qianlie Kangshu capsule group, # P<0.05; compared with the Ganoderma lucidum ordinary fine powder group, □ P<0.05.
[0029] The rats in each group were weighed 2 hours after the last intragastric administration and then killed by cervical dislocation. The abdominal cavity was immediately opened, the tissues around the prostate were separated, the prostate was taken out, the accompanying tissues were removed, the surface liquid was blotted with filter paper, and the wet weight of the prostate was weighed with a balance to calculate the wet weight index of the prostate. The wet weight index of the prostate = wet weight of the prostate / body weight of the rat.
[0030] Table 4 Comparison of prostate wet mass index in rats of each group after oral administration Note: Compared with the sham operation group, P<0.05; compared with the model group, △ P<0.05; compared with the Qianlie Kangshu capsule group, # P<0.05; compared with the Ganoderma lucidum ordinary fine powder group, □ P<0.05.
[0031] The test results show that superfine Ganoderma lucidum powder can restore the weight gain rate of the chronic prostatitis model induced by estrogen in castrated rats, which is significantly different from ordinary Ganoderma lucidum powder. As can be seen from Table 4, Ganoderma lucidum powder is effective for prostatitis, and the effect of superfine powder is significantly better than that of ordinary fine powder group.
[0032] The above is only an embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included in the scope of the claims of the present application.
Claims
1. An application of Ganoderma lucidum in preparing a medicine for treating prostatitis.
2. The use according to claim 1, It is characterized in that The ganoderma lucidum is a raw product or a processed product.
3. The use according to claim 1, It is characterized in that The ganoderma lucidum is a broken wall powder, with a moisture content of no more than 17%, a water-soluble extract of no less than 3.0%, a polysaccharide content of no less than 0.90%, and a triterpenoid and sterol content of no less than 0.50%; the particles larger than 30µm in the powder do not exceed 10%, and there are no particles larger than 40µm.
4. The use according to claim 3, It is characterized in that The preparation method of the ganoderma lucidum wall-broken powder comprises the following steps: (1) Sterilize the Ganoderma lucidum fruiting body and crush it into fine powder; (2) Ultrafine grinding the fine powder to a particle size of 2-30 μm to obtain Ganoderma lucidum wall-broken powder.
5. The use according to claim 4, It is characterized in that The sterilization is radiation sterilization, microwave sterilization or high temperature and high pressure sterilization.
6. The use according to claim 4, It is characterized in that The sterilization is microwave sterilization; the microwave sterilization time is 1.5-5 minutes; the microwave power is 400-600W.
7. The use according to claim 4, It is characterized in that The ganoderma lucidum fruiting body slices have a thickness of 2-5 mm; the fineness of the fine powder is 10-120 meshes.
8. The use according to claim 4, It is characterized in that The ultrafine grinding is a dry grinding method, which is selected from the methods of air flow grinding, vibration ultrafine grinding, ball milling ultrafine grinding, hammering ultrafine grinding and self-grinding ultrafine grinding.
9. The use according to claim 1, It is characterized in that The drug further comprises pharmaceutically acceptable excipients.
10. The use according to claim 1, It is characterized in that The dosage form of the medicine is selected from granules, tablets, capsules, syrups, wines and tinctures.
Citation Information
Patent Citations
Preparation method and use for pollution-free ganoderma lucidum ultrafine powder
CN102512459A
Ultrafine shell-broken Ganoderma Lucidum composition and preparation method thereof
CN104095886A
